Keros Therapeutics
Price & Volume
Stats
See more52W Range | $9.77-$73 |
Market Cap | $458.1M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $651,000 |
Revenue Growth (YoY) | 4,750% |
Gross Profit (12 Mos) | -$164.8M |
Diluted EPS | -$5.22 |
News
See moreYahoo Finance • 5 days ago
KEROS ALERT: Bragar Eagel & Squire, P.C. is Investigating Keros Therapeutics, Inc. on Behalf of Keros Stockholders and Encourages Investors to Contact the Firm
Yahoo Finance • last year
Keros Therapeutics to Present at Upcoming Healthcare Conferences
Yahoo Finance • last year
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2023 Financial Results
Yahoo Finance • last year
Keros Therapeutics to Present at the 65th American Society of Hematology Annual Meeting and Exposition
About
CEO | Dr. Jasbir S. Seehra Ph.D. |
Address | 1050 Waltham Street, Lexington, MA, United States, 02421 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 160 |
